GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPd3Z3UjlLZ1p1dURRZVBEZHZYbG1pNUtfUFRYM2NGeW1RWkFoUndGYmVveUJHd2FZeDQzYWtXbjR2d1FRZ25KcjQzeFFQcVp5TFo3VmNJcUFLRjR4Uk9LekpPanZHZUhRX24wLUVMS3hLREN0bmozdnFNNGI2VmZSMTd5dm5nSGl4S2hya2I0c29aWDJsVlVWeFM1cnZhZ1hDNjJwQUFJeDRDc0x3RGotczlOTHk1WGdjVWYxam90RE95bXUzdEU3WjlpTkxHOVJIWDRsMw?oc=5" target="_blank">GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMWHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PM